Metraipolis › archive › dc_35574bdafee7

Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications — Europe PMC PMID:42198457

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42198457
DOI
10.3390/ph19050783
License (as archived)
solo-consultazione
Archived
2026-11-02T05:38:23.522Z
SHA-256 of the archived text
64e0a6ad5286aca1e5212ebfae49d63872b71f31025ce1a04f13362cdc8fa2e5
Stable URL of this page
https://metraipolis.com/documento/dc_35574bdafee7

How to cite

Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications — Europe PMC PMID:42198457 — Europe PMC (en), https://europepmc.org/article/MED/42198457 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35574bdafee7 (Metraipolis archive dc_35574bdafee7, sha256 64e0a6ad5286aca1e5212ebfae49d63872b71f31025ce1a04f13362cdc8fa2e5)
BibTeX
@misc{dc35574bdafee7,
  title = {Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications — Europe PMC PMID:42198457},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42198457},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35574bdafee7; sha256 64e0a6ad5286aca1e5212ebfae49d63872b71f31025ce1a04f13362cdc8fa2e5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198457. Agents can read the archived copy with the MCP tool read_document.